Cough - Airway Pellet
NDC Package 55714-2415-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cough - Airway (influenza a virus, influenza b virus, antimon. tart., arsenicum alb., bryonia, chelidonium majus, cinchona, drosera, eucalyptus, histaminum hydrochloricum, hydrastis, kali bic., kali carb., kali iod., myrrha, nat. sulphuricum, nux vom., phosphorus, pulsatilla, rumex crisp., sambucus nig., spongia, tussilago farfara, verbascum, echinacea, lappa) pellets is formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, dryness and painful breathing. This formulation utilizes a pellet delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-2415.

Identification & Billing

NDC Package Code
55714-2415-1
Package Description
28 g in 1 BOTTLE, GLASS
Product Code
55714-2415
11-Digit Billing Format
55714241501

Clinical Specifications

Proprietary Name
Cough - Airway
Non-Proprietary Name
Influenza A Virus, Influenza B Virus, Antimon. Tart., Arsenicum Alb., Bryonia, Chelidonium Majus, Cinchona, Drosera, Eucalyptus, Histaminum Hydrochloricum, Hydrastis, Kali Bic., Kali Carb., Kali Iod., Myrrha, Nat. Sulphuricum, Nux Vom., Phosphorus, Pulsatilla, Rumex Crisp., Sambucus Nig., Spongia, Tussilago Farfara, Verbascum, Echinacea, Lappa
Substance Name
Antimony Potassium Tartrate; Arctium Lappa Root; Arsenic Trioxide; Bryonia Alba Root; Chelidonium Majus; Cinchona Officinalis Bark; Drosera Rotundifolia Flowering Top; Echinacea, Unspecified; Eucalyptus Globulus Leaf; Goldenseal; Histamine Dihydrochloride; Influenza A Virus; Influenza B Virus; Myrrh; Phosphorus; Potassium Carbonate; Potassium Dichromate; Potassium Iodide; Pulsatilla Vulgaris; Rumex Crispus Root; Sambucus Nigra Flowering Top; Sodium Sulfate; Spongia Officinalis Skeleton, Roasted; Strychnos Nux-vomica Seed; Tussilago Farfara; Verbascum Thapsus
Dosage Form
Pellet - A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Formulated for symptoms such as wheezing, shortness of breath, congestion, coughing, dryness and painful breathing.

Regulatory & Marketing

Labeler Name
Newton Laboratories, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
01-31-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55714-2415-1 identifies a specific commercial package of 28 g in 1 bottle, glass of Cough - Airway, a human over the counter drug labeled by Newton Laboratories, Inc.. This pellet is formulated for oral use and contains antimony potassium tartrate; arctium lappa root; arsenic trioxide; bryonia alba root; chelidonium majus; cinchona officinalis bark; drosera rotundifolia flowering top; echinacea, unspecified; eucalyptus globulus leaf; goldenseal; histamine dihydrochloride; influenza a virus; influenza b virus; myrrh; phosphorus; potassium carbonate; potassium dichromate; potassium iodide; pulsatilla vulgaris; rumex crispus root; sambucus nigra flowering top; sodium sulfate; spongia officinalis skeleton, roasted; strychnos nux-vomica seed; tussilago farfara; verbascum thapsus as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on January 31, 2019. The current certification is valid through December 31, 2026.

How is this Newton Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714241501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55714-2415-1
11-Digit CMS (5-4-2)
55714-2415-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.